Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1

OBJECTIVE: Celastrol was recently identified as a potential novel treatment for obesity. However, the effect of Celastrol on nonalcoholic fatty liver disease (NAFLD) remains elusive. The aim of this study is to evaluate the role of Celastrol in NAFLD. METHODS: Functional studies were performed using...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Metab
Päätekijät: Zhang, Yinliang, Geng, Chao, Liu, Xiaoyan, Li, Meixia, Gao, Mingyue, Liu, Xiaojun, Fang, Fude, Chang, Yongsheng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2016
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5220393/
https://ncbi.nlm.nih.gov/pubmed/28123944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2016.11.002
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia